BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2793265)

  • 1. Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease.
    Koch G; Fransson L
    Int J Cardiol; 1989 Oct; 25(1):73-9. PubMed ID: 2793265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects at rest and during exercise of combined alpha/beta-receptor blockade and of beta-receptor blockade alone in patients with ischemic heart disease.
    Koch G; Fransson L
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):474-8. PubMed ID: 2444802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G
    Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic analysis of the effects of nicardipine and metoprolol alone and in combination in coronary artery disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Jackson N; Taylor SH
    Eur Heart J; 1985 Nov; 6(11):930-8. PubMed ID: 4076202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Forsyth D; Taylor SH
    Eur Heart J; 1984 Jan; 5(1):67-79. PubMed ID: 6705807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A haemodynamic study of the effects of combined slow-calcium channel blockade (nisoldipine) and beta-blockade (metoprolol) in coronary heart disease.
    Silke B; Verma SP; Midtbo KA; Müller P; Frais MA; Reynolds G; Taylor SH
    Int J Cardiol; 1986 Nov; 13(2):231-41. PubMed ID: 3793280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
    Feldman RL; Prida XE; Hill JA
    Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
    Renard M; Jacobs P; Liebens I; Abou Hamdam B; Bernard R
    Int J Cardiol; 1986 Feb; 10(2):149-58. PubMed ID: 3080379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in exercise capacity and associated changes in hemodynamics and left ventricular function after the addition of metoprolol to nifedipine in patients with stable exertional angina.
    Choong CY; Roubin GS; Shen WF; Tokuyasu Y; Harris PJ; Kelly DT
    Clin Cardiol; 1985 Apr; 8(4):213-24. PubMed ID: 3987110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
    Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
    J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE; Hill JA; Feldman RL
    Am J Cardiol; 1987 May; 59(12):1084-8. PubMed ID: 2883869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of nitroglycerin, nifedipine and metoprolol on regional left ventricular function in patients with one-vessel coronary disease.
    Pfisterer M; Glaus L; Burkart F
    Circulation; 1983 Feb; 67(2):291-301. PubMed ID: 6401230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.
    Prida XE; Feldman RL; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):244-8. PubMed ID: 2887101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
    Feldman RL; Prida XE; Lambert CR; Hill JA
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):355-61. PubMed ID: 3155428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and clinical findings after combined therapy with metoprolol and nifedipine in acute myocardial infarction.
    Emanuelsson H; Herlitz J; Hjalmarson A; Holmberg S; Waagstein F; Waldenström A; Waldenström J
    Clin Cardiol; 1984 Aug; 7(8):425-32. PubMed ID: 6380856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal drug effects on normal, ischemic and scar myocardial segments in man.
    Pfisterer M; Fridrich R; Burkart F
    Scand J Clin Lab Invest Suppl; 1984; 173():65-73. PubMed ID: 6442004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
    Silke B; Verma SP; Guy S
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):681-7. PubMed ID: 1679661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
    Ohman KP; Weiner L; von Schenck H; Karlberg BE
    Eur J Clin Pharmacol; 1985; 29(2):149-54. PubMed ID: 3908121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.